Trelegy Ellipta filing accepted by EMA for asthma
As it stands there is no single inhaled triple therapy available for the treatment of asthma in Europe.
Read More
Tag: Trelegy
GSK picks Kevin Sim to lead business development for pharma R&D
GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D.
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
